DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,318,957 | -3.5% | 1,037,167 | -15.6% | 0.00% | 0.0% |
Q2 2023 | $15,876,057 | +19.8% | 1,228,797 | -9.0% | 0.00% | 0.0% |
Q1 2023 | $13,251,818 | -4.8% | 1,350,848 | +3.2% | 0.00% | 0.0% |
Q4 2022 | $13,921,833 | -2.7% | 1,308,443 | -4.6% | 0.00% | -20.0% |
Q3 2022 | $14,312,000 | -11.8% | 1,370,938 | +6.4% | 0.01% | 0.0% |
Q2 2022 | $16,218,000 | +163.8% | 1,288,156 | +127.2% | 0.01% | +150.0% |
Q1 2022 | $6,147,000 | -21.7% | 567,023 | +1.6% | 0.00% | 0.0% |
Q4 2021 | $7,854,000 | -33.0% | 558,213 | -8.5% | 0.00% | -33.3% |
Q3 2021 | $11,724,000 | +2937.3% | 610,286 | +1455.4% | 0.00% | – |
Q2 2021 | $386,000 | +48.5% | 39,236 | +48.6% | 0.00% | – |
Q1 2021 | $260,000 | +170.8% | 26,398 | +22.5% | 0.00% | – |
Q4 2020 | $96,000 | -89.5% | 21,551 | -86.6% | 0.00% | – |
Q4 2019 | $917,000 | +1156.2% | 160,301 | +682.4% | 0.00% | – |
Q3 2019 | $73,000 | -14.1% | 20,489 | -3.5% | 0.00% | – |
Q2 2019 | $85,000 | -47.2% | 21,238 | -3.3% | 0.00% | – |
Q1 2019 | $161,000 | -97.2% | 21,962 | -94.2% | 0.00% | -100.0% |
Q2 2018 | $5,740,000 | -38.2% | 376,371 | -24.2% | 0.00% | -33.3% |
Q4 2017 | $9,286,000 | +54.3% | 496,592 | +77.4% | 0.00% | +50.0% |
Q3 2017 | $6,018,000 | +1094.0% | 279,905 | +435.8% | 0.00% | – |
Q2 2017 | $504,000 | +65.2% | 52,239 | +1.8% | 0.00% | – |
Q1 2017 | $305,000 | -80.3% | 51,340 | -36.2% | 0.00% | -100.0% |
Q1 2016 | $1,549,000 | -60.1% | 80,527 | -49.8% | 0.00% | -50.0% |
Q4 2015 | $3,879,000 | +4.8% | 160,536 | +6.4% | 0.00% | 0.0% |
Q3 2015 | $3,701,000 | +61583.3% | 150,810 | +60224.0% | 0.00% | – |
Q2 2015 | $6,000 | – | 250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |